Development of novel neutralizing single-chain fragment variable antibodies against S100A8
Abstract S100A8 plays a critical role in the pathogenesis of several inflammatory diseases and multiple types of cancer. Therefore, targeting the S100A8 function may alleviate the pathogenic process in various diseases. Here, specific single-chain variable fragment (scFv) antibodies targeting recomb...
Saved in:
| Main Authors: | Hamideh Raeisi, Masoumeh Azimirad, Alexandru Schiopu, Amir-Hassan Zarnani, Hamid Asadzadeh Aghdaei, Elham Abdemohamadi, Mohammad Reza Zali, Abbas Yadegar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-96211-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery and in vitro characterization of a human anti-CD36 scFv
by: Cecilia Mata-Cruz, et al.
Published: (2025-02-01) -
Novel single-chain fragment variable antibody targeting plasma membrane epitopes on porcine Y-chromosome-bearing sperm
by: Marninphan Thongkham, et al.
Published: (2025-05-01) -
Single-step colony assay with autoinduction of scFv expression for the screening of antibody libraries
by: Mieko Kato, et al.
Published: (2019-04-01) -
Cost-effective production process of scFv antibody fragments against Shiga toxin 2 via recombinant E. coli
by: Marcela Guimarães, et al.
Published: (2025-01-01) -
Revolutionizing oncology: the role of Artificial Intelligence (AI) as an antibody design, and optimization tools
by: Varun Dewaker, et al.
Published: (2025-03-01)